Huahai Pharmaceutical's "Huahai convertible bonds" maintain AA rating

Zhejiang Huahai Pharmaceutical (SSE:600521) announced that its "Huahai Convertible Bonds" have maintained an AA credit rating, with a stable outlook, following a follow-up assessment by Shanghai Orient Credit Rating. The assessment, detailed in the "2020 Zhejiang Huahai Pharmaceutical Co., Ltd. Public Offering of Convertible Corporate Bonds Periodic Follow-up Rating Report" [New Century Tracking (2025) 100187], reaffirms the company's strong creditworthiness and the bond's investment grade status. The company's overall issuer rating was also maintained at AA with a stable outlook.